Anhui Huaheng Biotechnology Balance Sheet Health
Financial Health criteria checks 2/6
Anhui Huaheng Biotechnology has a total shareholder equity of CN¥1.9B and total debt of CN¥2.0B, which brings its debt-to-equity ratio to 110.1%. Its total assets and total liabilities are CN¥4.7B and CN¥2.8B respectively. Anhui Huaheng Biotechnology's EBIT is CN¥328.7M making its interest coverage ratio 11.8. It has cash and short-term investments of CN¥445.3M.
Key information
110.1%
Debt to equity ratio
CN¥2.04b
Debt
| Interest coverage ratio | 11.8x |
| Cash | CN¥445.31m |
| Equity | CN¥1.86b |
| Total liabilities | CN¥2.85b |
| Total assets | CN¥4.70b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 688639's short term assets (CN¥1.2B) do not cover its short term liabilities (CN¥2.1B).
Long Term Liabilities: 688639's short term assets (CN¥1.2B) exceed its long term liabilities (CN¥796.8M).
Debt to Equity History and Analysis
Debt Level: 688639's net debt to equity ratio (86.1%) is considered high.
Reducing Debt: 688639's debt to equity ratio has increased from 20.9% to 110.1% over the past 5 years.
Debt Coverage: 688639's debt is not well covered by operating cash flow (1.8%).
Interest Coverage: 688639's interest payments on its debt are well covered by EBIT (11.8x coverage).